Asia-Pacific Longevity Society

SAVE THE DATES! The Asia‑Pacific Healthy Longevity International Summit will focus on these core themes and topics. It is jointly presented by the Asia‑Pacific Longevity Medicine Society and the Kitalys Institute.

SAVE THE DATES! The Asia‑Pacific Healthy Longevity International Summit will be held at the Hopewell Hotel, Hong Kong, from Oct. 1–4, featuring two days of pre‑summit training programs and two days of main sessions. It is jointly presented by the Asia‑Pacific Longevity Medicine Society and the Kitalys Institute.

The Asia-Pacific Longevity Medicine Society has officially announced that the 2026 Asia-Pacific Longevity Medicine International Summit will be held in Hong Kong from October 1–4, 2026. The program will include two days of pre-conference activities: October 1 will feature the “Longevity Top 10 Breakthrough Award Gala,” and October 2 will offer four comprehensive training programs on best practices for longevity clinics. The main APLMS Summit sessions will take place on October 3–4.

Some people believe it’s unnecessary, while others are convinced it’s beneficial for better health. It’s difficult to definitively prove who is right. However, there is one key issue we must focus on: has a proper safety assessment been conducted? It is not enough to simply say, “Yes, it’s safe.” Safety must be demonstrated with documented, formal assessment—this is not optional.

Chinese New Year holiday/Happy Lunar New Year! The Asia-Pacific Longevity Medicine Society is pleased to announce that the 2026 APAC Longevity Medicine International Summit will be held in Hong Kong from October 1–4, 2026. We expect to welcome more than 2,000 participants from around the world.

With today's launch of “A Giant Leap,” there’ll be lots of great podcasts on which I discuss AI and healthcare. Two today: Health Affairs Podyssey (w/ HA editor Rob Lott): healthaffairs.org/do/10.1377/hp2… Health & Veritas (w/ Yale’s Harlan Krumholz & Howie Forman): insights.som.yale.edu/podcasts/healt…

Really enjoyed this convo with Graham Walker, ED doc & inventor of MDCalc, on his "How I Doctor" podcast. Graham's comment that, when he's crossing a SF intersection, he worries more when he sees a car with a driver coming than a Waymo has stuck with me. offcall.com/learn/podcast/…

The one from me

The vicious cycle of heart complications from many cancer treatments @jclinicalinvest jci.org/articles/view/…

AI doesn't need to be perfect to outperform our healthcare system's woeful status quo. It just needs to be better. In many cases, it already is. In today's @nytimes, I explore this idea – a central theme of my upcoming book, A Giant Leap (out Feb 3). nytimes.com/2026/01/19/opi…

A very exciting book day in my household – on the same day I received my copy of @ZekeEmanuel's new book (which I'm psyched to read), a pre-pub copy of my new book showed up as well. Mine will be publicly available on Feb 3, but available for pre-order now.

Large health models and predicting diseases —In September, >1,200 diseases predicted and when, by EHR and lifestyle factors, for 20-years forward nature.com/articles/s4158… —Yesterday, >130 diseases were predicted from 1 night of sleep data and EHR (Figure) nature.com/articles/s4159…

@TimShiTIME1 This is the market signal we’ve been waiting for. The new CSEDB benchmark in npj Digital Medicine validates the Vertical AI thesis: general LLMs can’t compete with specialized models on high-stakes clinical tasks. A China-driven standard + MedGPT performance = real differentiation and smarter VC capital. #VentureCapital #HealthTech #AI_Ecosystem#MedGPT#DigitalHealth#HealthTech#AI@futuredoctorcn

There's a few companies out there trying to reverse aging curated by @Stifel

Dr. Makoto Suzuki, age 92, is the leading professor on Japan’s “Blue Zone” in Okinawa and has dedicated more than 60 years to studying longevity in this region. Dr. Suzuki delivered an outstanding lecture titled “Challenge for Longevity: Longevity and Healthy Ageing—What Can We Learn from the Blue Zone?” sharing his unique insights and lifelong experience (Nov. 3rd 2025).

Dr. Tim Shi, Chairman of the Asia-Pacific Longevity Medicine Society(APLMS), and Professor Shigeo Horie, Leader of the Japan Longevity Consortium, have signed an MOU to jointly promote the APLMS Acceleration and Validation Center project in Hong Kong. This partnership is extremely meaningful, providing a critical bridge between scientific innovation, clinical validation, and real-world implementation in the Asia-Pacific region. We strongly support this initiative and look forward to deepening our collaboration under the APLMS framework and our existing MOU.

At the APAC Longevity Medicine International Summit, Prof. Andrew Scott, a leading longevity economist, discussed how the Asia‑Pacific region is transforming from a “silver economy” to an “evergreen economy.” Over the next 30 years, some Asian countries are projected to have up to 40% of their population aged 65 and above. He emphasized that this demographic shift shouldn't be viewed solely as a challenge, but as an opportunity to understand and harness the power of a “longevity‑driven evergreen superpower.”(apaclongevitysociety.org)

APAC Longevity Medicine International Summit: Panelists from China (Mainland and Hong Kong), Singapore, Thailand, France, Australia, and the United States expressed a wide range of healthy, diverse perspectives on best practices for longevity clinics.(apaclongevitysociety.org)